Osteocyte Regulation of Receptor Activator of NF-κB Ligand/Osteoprotegerin in a Sheep Model of Osteoporosis.

Explore this paper's citation graph

Summary

Assessment of the osteocyte-specific RankL/OPG ratio showed that the steroid-induced osteoporosis in its late progressive phase stimulates RANKL expression in osteocytes, which can contribute to further explain the success of sclerostin antibodies in treating osteopootic patients despite increased osteocytes-expressed RANKG.

Type
article
Published
2017-08-01
Cited by
20
References
61
Access
Open access

Keywords

RANKL, Osteoprotegerin, Sclerostin, Osteocyte, Endocrinology

References

Cited by

Related papers